Visium Asset Management’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Visium Asset Management’s Portfolio OMED Stock Details OMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-238,289	Closed	-$5.37M	–	747
2015 Q4	$5.37M	Buy	238,289 +163,189	+217%	+$3.34M	0.08%	272
2015 Q3	$1.25M	Buy	+75,100	New	+$1.51M	0.02%	494
2014 Q4	–	Sell	-75,001	Closed	-$1.42M	–	1355
2014 Q3	$1.42M	Hold	75,001	–	–	0.02%	527
2014 Q2	$1.75M	Hold	75,001	–	–	0.03%	438
2014 Q1	$2.52M	Buy	75,001 +1	+0%	+$34	0.04%	348
2013 Q4	$2.21M	Sell	75,000 -800	-1%	-$14.7K	0.04%	331
2013 Q3	$1.16M	Buy	+75,800	New	+$1.4M	0.03%	393

Other funds holding OMED

ASP

Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IHM

Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Visium Asset Management's OMED Position: Q1 2016 in Review

Visium Asset Management sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q1 2016, closing a stake of 238,289 shares — an estimated $5.37M sold.

Visium Asset Management first reported a position in OMED in Q3 2013 and held it in 7 quarters. The position peaked at $5.37M in Q4 2015. 83 funds tracked by Wall St. Rank hold OMED as of Q1 2016.

Visium Asset Management reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
Visium Asset Management sold 238,289 OncoMed Pharmaceuticals, Inc. shares in Q1 2016, an estimated $5.37M.
Visium Asset Management first reported a position in OncoMed Pharmaceuticals, Inc. in Q3 2013 and held it in 7 quarters.
Visium Asset Management's OncoMed Pharmaceuticals, Inc. position peaked at $5.37M in Q4 2015.
83 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q1 2016.

Based on Visium Asset Management's 13F filing for Q1 2016, filed 16 May 2016.